Promotie onderzoek

KNMP stelt wetenschappelijk onderzoek voorop. Hier kunt u de meest recente onderzoeken vinden.
Er zijn28resultaten gevonden
Farmacokinetiek en -dynamiek

A Dried blood spot sampling method for VANcomycin and Creatinine monitoring: Earning higher patient satisfaction and a Decrease in costs in Outpatient Parenteral Antibiotic Therapy service (ADVANCED OPAT)

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Moska Hassanzai
  • Promoters prof. dr. Birgit Koch
  • Co-Promoters ds dr. Brenda C.M. de Winter Hein van Onzeoort
  • Jaar 2021

Outpatient Parenteral Antimicrobial Therapy (OPAT) service provides antimicrobial therapy by parenteral infusion without hospitalization. Vancomycin is a widely used antibiotic in OPAT, however a drawback of its application in OPAT is the need for traditional blood sampling at a blood sampling facility for therapeutic drug monitoring. By developing a dried blood spot sampling method (i.e. a finger prick), enabling patients to collect their own sample at home, the costs of OPAT may be further reduced and patient satisfaction may be increased. 

Medicatieveiligheid

Improving pharmaceutical care for hospitalized patients

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Sarah Wilkes
  • Promoters prof. dr. Hugo van der Kuy
  • Co-Promoters ds dr. R.J. Zaal
  • Jaar 2022-2026
  1. Cost benefit analysis clinical medication reviews
  2. Follow up of intervetnions from clinical pharmacists.
  3. Medication information needs of hospitalized patients.
Farmacokinetiek en -dynamiek

Exploratory PK/PD study of beta-lactam antibiotics in pediatric intensive care patients

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Stef Schouwenburg
  • Promoters prof. dr. Birgit Koch
  • Co-Promoters ds Dr. E.D. (Enno) Wildschut Prof. Dr. M. (Matthijs) de Hoog A. (Alan) Abdulla
  • Jaar 2021-2025

 A prospective observational PK/PD to study the target attainment for β-lactam antibiotics in critically ill pediatric patients and associated risk factors.

Medicatieveiligheid

The metabolisation of drugs as a factor in the development of adverse drug reactions

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus N. Jessurun
  • Promoters Prof dr E.P. van Puijenbroek Prof dr R.J. van Marum
  • Co-Promoters ds Dr H.J. Derijks Dr K Grootens
  • Jaar 2018-2022

The aim of this PhD is to study the role of drug metabolism in adverse drug reactions (ADRs), an area which is not often taken into account in pharmacovigilance. The role of metabolites in ADRs is studied by focusing on (but not limiting to) a number of  therapeutic drug groups.

Medicatieveiligheid

From prescription-based monitoring towards continuous pharmaceutical care in community pharmacy

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Ellen van Loon
  • Promoters K. Taxis M. Bouvy
  • Co-Promoters ds M. Heringa
  • Jaar 2019-2024

Onderzoeksprojekt over de mogelijkheden die de beweging naar continue
farmaceutische patiëntenzorg helpen mogelijk te maken dan wel te versnellen.

Medicatieveiligheid

Health Alliance for Prudent Prescription and Yield of Antibiotics in a Patient-centred Perspective (HAPPY PATIENT) – the role of community pharmacies

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Maarten Lambert
  • Promoters K. Taxis L van Dijk
  • Jaar 2021-2025

European funded project to reduce the inappropriate use of antibiotics in common infectious diseases by implementing EU guidelines for the prudent use of antimicrobials in human health. Implementing the Audit Project Odense (APO) methodology in community pharmacies in 5 European countries (France, Spain, Lithuania, Poland and Greece).

Medicatieveiligheid

Pharmaceutical care for hypertension patients

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus I. Treciokiene
  • Promoters K. Taxis M. Postma
  • Jaar 2015-2023

Drug utilization of antihypertensives in the Baltic countries.

Pagina 3 van 4